Login / Signup

Safety Consequences of Off-Label Drugs Used for COVID-19.

Nabarun Dasgupta
Published in: Drug safety (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus